Global Blood Therapeutics

Home » Global Blood Therapeutics

Secondary

Global Blood Therapeutics

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

Symbol

GBT

Last Closing Price
$39.40

Shares
2,600,000

Effective Date
December 15, 2017

Underwriters
Cantor Fitzgerald

To view the prospectus for Global Blood Therapeutics , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253